Skip to main content
. 2019 Jan 11;55(1):10. doi: 10.3390/medicina55010010

Figure 4.

Figure 4

Histopathological slides of all treatment groups in which Series 1 represents kidney, where 1 is the control group, (1A) treatment with 5 ppm T-NPs, (1B) treatment with 10 ppm T-NPs, (1C) treatment with 20 ppm T-NPs; Series 2 represents liver, where 2 is the control group, (2A) treatment with 5 ppm T-NPs, (2B) treatment with 10 ppm T-NPs, (2C) treatment with 20 ppm T-NPs; and Series 3 represents muscle, where 3 is the control group, (3A) treatment with 5 ppm T-NPs, (3B) treatment with 10 ppm T-NPs, (3C) treatment with 20 ppm T-NPs. All images were taken at 40× optical zoom.